http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-20011093-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-91 |
| filingDate | 1999-09-21^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d4e15284299e30d03828fc3e1387e19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_777ddbb5fae24e6edef995ed66ff4c95 |
| publicationDate | 2001-07-11^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CZ-20011093-A3 |
| titleOfInvention | Amide derivatives which are useful as inhibitors of cytokine production, a process for their preparation, and a pharmaceutical composition containing them |
| abstract | The present invention relates to amide derivatives of the general formula I wherein R 3nto alkyl of 1 to 6 carbon atoms or halogen; m isn0 to 3, p is 0 to 2 and q is 0 to 4; each R 1 and R 2 is selected fromna group comprising a hydroxy group, a halogen atom,ntrifluoromethyl and cyano and R4 is basicna group such as amino, alkylamino,ndi (alkyl) amino having 1 to 6 carbon atoms in each alkylnpart, di (alkyl) aminoalkyl having 1 to 6 carbon atoms inneach alkyl moiety, di (alkyl) aminoalkoxy having 1 to 6ncarbon atoms in the alkyl moiety and 2-6 carbon atoms innalkoxy, heteroaryl, heteroaryloxy,nC 1 -C 6 heteroarylalkoxy in alkoxynmoieties, heterocyclyl, heterocyclyloxy, andnC 1 -C 6 heterocyclylalkoxy in alkoxynparts; and Q 2 is a group such as heteroaryl, heteroaryloxy ornC 1 -C 6 heteroarylalkoxy optionallynsubstituted; or a pharmaceutically acceptable salt thereofnor in vivo cleavable esters; ways of preparing them,npharmaceutical compositions containing them and their usesnfor treating cytokine mediated diseases or conditions |
| priorityDate | 1999-09-21^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 702 of 702.